Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
2.350
-0.040 (-1.67%)
Oct 29, 2025, 1:36 PM EDT - Market open
Aclaris Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$9.25
Upside
+293.62%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +580.85% | Oct 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $6 | Buy | Initiates | $6 | +155.32% | Jul 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +580.85% | Jun 25, 2025 |
| Wedbush | Wedbush | Buy Initiates $8 | Buy | Initiates | $8 | +240.43% | May 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $16 | Strong Buy | Maintains | $20 → $16 | +580.85% | May 14, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $15 → $9 | Buy | Maintains | $15 → $9 | +282.98% | May 9, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Mar 18, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $15 | Buy | Initiates | $15 | +538.30% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $20 | Hold → Strong Buy | Upgrades | $20 | +751.06% | Dec 23, 2024 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $2 → $7 | Hold → Buy | Upgrades | $2 → $7 | +197.87% | Nov 19, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $2 → $7 | Hold → Strong Buy | Upgrades | $2 → $7 | +197.87% | Nov 19, 2024 |
| BTIG | BTIG | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +240.43% | Nov 19, 2024 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $3 → $13 | Hold → Buy | Upgrades | $3 → $13 | +453.19% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 22, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.